1. Home
  2. HBCP vs RLMD Comparison

HBCP vs RLMD Comparison

Compare HBCP & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Home Bancorp Inc.

HBCP

Home Bancorp Inc.

HOLD

Current Price

$66.26

Market Cap

533.0M

Sector

Finance

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBCP
RLMD
Founded
1908
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.0M
461.9M
IPO Year
2008
2012

Fundamental Metrics

Financial Performance
Metric
HBCP
RLMD
Price
$66.26
$3.75
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
★ $65.50
$12.40
AVG Volume (30 Days)
42.0K
★ 1.2M
Earning Date
04-20-2026
05-08-2026
Dividend Yield
★ 1.98%
N/A
EPS Growth
29.01
★ 45.28
EPS
★ 2.93
N/A
Revenue
N/A
★ $13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.97
N/A
P/E Ratio
$22.65
★ N/A
Revenue Growth
N/A
★ 154.83
52 Week Low
$50.54
$1.80
52 Week High
$74.50
$8.00

Technical Indicators

Market Signals
Indicator
HBCP
RLMD
Relative Strength Index (RSI) 32.24 31.32
Support Level $64.88 $3.59
Resistance Level $71.28 $4.51
Average True Range (ATR) 1.28 0.22
MACD -0.21 -0.02
Stochastic Oscillator 3.97 8.59

Price Performance

Historical Comparison
HBCP
RLMD

About HBCP Home Bancorp Inc.

Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities.It is holding company for Home Bank, N.A. The principal sources of funds are customer deposits, repayments of loans, repayments of investments, and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: